Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-26-000644
Filing Date
2026-02-25
Accepted
2026-02-25 16:23:33
Documents
2
Period of Report
2026-02-20

Document Format Files

Seq Description Document Type Size
1 zk2634447.html 4  
1 zk2634447.xml 4 9030
2 EXHIBIT 24.1 exhibit_24-1.htm EX-24.1 7344
  Complete submission text file 0001178913-26-000644.txt   17845
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Issuer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 6 JACOB AFTER STREET TEL AVIV L3 6936206
Business Address
Noy Shlomo (Reporting) CIK: 0002033211 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42253 | Film No.: 26679025